Chronic myeloid leukemia stem cells: targeting therapeutic implications

Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasm driven by BCR-ABL1 oncoprotein, which plays a pivotal role in CML pathology, diagnosis, and treatment as confirmed by the success of tyrosine kinase inhibitor (TKI) therapy. Despite advances in the development of more potent tyro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mojtahedi, Hanieh, Yazdanpanah, Niloufar, Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684082/
https://www.ncbi.nlm.nih.gov/pubmed/34922630
http://dx.doi.org/10.1186/s13287-021-02659-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684082/
https://www.ncbi.nlm.nih.gov/pubmed/34922630
http://dx.doi.org/10.1186/s13287-021-02659-1

Ejemplares similares